BACKGROUND: Due to the high satiating effect of protein, a high-protein diet may be desirable in the treatment of obesity. However the long-term effect of different levels of protein intake on renal function is unclear. OBJECTIVE: To assess the renal effects of high vs low protein contents in fat-reduced diets. DESIGN: Randomized 6 months dietary intervention study comparing two controlled ad libitum diets with 30 energy (E%) fat content: high-protein (HP; 25 E%) or low-protein, (LP, 12 E% protein). All food was provided by self-selection in a shop at the department, and high compliance to the diet composition was con®rmed by measurements of urinary nitrogen excretion. SUBJECTS: 65 healthy, overweight and obese (25`body mass index (BMI)`34 kgam 2 ). RESULTS: Dietary protein intake changed from 91.1 gad to a 6 months intervention average of 70.4 gad (P`0.05) in the LP group and from 91.4 gad to 107.8 gad (P`0.05) in the HP group, producing changes in glomular ®ltration rate (GFR) of 7 7.1 mlamin in the LP group and 5.2 mlamin in the HP group (group effect: P`0.05). Kidney volume decreased by 7 6.2 cm 3 in the LP group and increased by 9.1 cm 3 in the HP group (P`0.05), whereas albuminuria remained unchanged in all groups. CONCLUSION: Moderate changes in dietary protein intake cause adaptive alterations in renal size and function without indications of adverse effects.
Introduction
Renal function as measured by glomerular ®ltration rate (GFR) is in¯uenced by physical characteristics such as age, gender, body size and pregnancy. In addition it has been recognized for many years that dietary protein in¯uences renal function. Efforts so far have primarily focused on the effect of dietary protein in renal disease, whereas renal effects of dietary protein in healthy subjects are lacking. The current concern for renal effects of a high protein intake derives mainly from indications of detrimental effects of the induced glomerular hyper®ltration, the association of which was corroborated in 1982 in a review by Brenner et al. 1 Recently a randomized strictly controlled dietary intervention study showed that replacement of some dietary carbohydrate by protein in ad libitum fatreduced diets, improved mean weight loss in obese subjects and increased the proportion of subjects achieving a clinically relevant weight loss. 2 A highprotein diet is not thought to be a new phenomenon in man, as anthropologic studies suggest that our ancestors consumed a diet with a protein content of approximately 30 energy %, derived mainly from animal products. 3 Nevertheless, there remains some uncertainty about possible adverse effects of a high protein intake on renal function.
Most studies have only examined the effects of acute protein loads on renal function, 4 whereas the effects of different levels of habitual protein intake have been addressed in observational studies. Recently it was observed that there is a highly signi®cant correlation between endogenous creatinine clearance, nitrogen excretion rate and albumin excretion rate in a population eating widely varying amounts of protein. 5 Therefore the aim of the present study was to examine more closely the impact of changes in dietary protein content on renal function in obese subjects. Determinants of renal function were examined in a cross-sectional study, and the long-term effect of a high-protein (25 E%) diet vs a low-protein (12 E%) diet was subsequently addressed in a strictly controlled intervention study.
Subjects and methods

Subjects
Sixty-®ve obese subjects (25`BMI`34 kgam 2 ) of both genders, aged 18 ± 56 y, were included in the study. All subjects were apparently healthy volunteers recruited through advertisements on a local television channel and from a waiting list. Before enrollment the subjects underwent a brief screening examination by a physician, including a medical history, a routine physical examination and blood tests. The medical history was performed in order to uncover actual and previous disorders, primarily of renal function, or metabolic diseases. The physical examination included inspection of the general condition, measurement of blood pressure, an auscultation of the heart and the lungs, palpation of the thyroid gland, breasts and abdomen. The blood tests included haemoglobin, white blood count, sodium, potassium, glucose and alkaline phosphatases. Urine dipsticks included blood, protein and glucose. Subjects were randomly assigned to the two dietary intervention groups (25 subjects each) or to the control group (15 subjects). To ensure group matching with respect to BMI, gender, age and smoking habits, a third party, who did not know the subjects or their identity, exchanged group membership of 6 subjects. The physical characteristics of the subjects are given in Table 1 .
Approval was obtained from the Municipal Ethical Committee of Copenhagen and Frederiksberg and the study was performed in accordance with the Helsinki II declaration. Each subject signed an informed consent document before the study commenced.
Study design
The study was divided into a cross-sectional and an intervention study. At baseline, physical characteristics including glomerular ®ltration rate, kidney volume and renal biochemistry were measured. In the intervention study subjects were randomly assigned to either a low-protein (LP) or a high-protein (HP) diet (both low in fat (30% of total energy)), or to a control group (C) ( Table 2 ). The dietary intervention was maintained for 6 months, macronutrient composition of the diet was strictly controlled but energy intake was unrestricted. Glomerular ®ltration rate, kidney volume and renal biochemistry analyses were measured at the termination of the study. The subjects were instructed not to change their physical activity pattern or smoking habits during the study.
Outcome measures
The study assessed dietary effects on body size and composition, and on blood lipids. These results have been reported in a separate publication. 2 The primary 
Diet
All the subjects' food was provided by self selection in a shop at the Department and could be consumed ad libitum. This method has been described in detail elsewhere. 6 The target composition of the two diets was: HP: 25% of energy (E%) as protein and 45 E% as carbohydrate; LP: 12 E% as protein and 58 E% as carbohydrate. The target composistion was set according to the nationwide survey of dietary habits in Denmark 1995, 7 from which it can be concluded that only 1% of the Danish population consumes a diet with a protein E% that exceeds that of the HP group and 5% consumes a diet with a protein E% of less than that of the LP group. The protein intake was monitored by an objective biological marker, 24 h urinary nitrogen excretion (24 h UN). Urine was collected at baseline, and at 3 and 6 months of the study.
Blood pressure
Blood pressure was measured automatically (UA-743, Tadeka, Japan) at baseline. Mean arterial blood pressure (BP) was calculated as: mean arterial BP diastolic blood pressure
Measurement of renal function and volume
Glomerular ®ltration rate. The GFR was measured after a single intravenous injection of 51 Cr-EDTA (3.7 MBq), by determining the radioactivity in venous blood samples drawn from the other arm 180, 200, 220 and 240 min after injection, according to the technique described by Brùchner-Mortensen. 8 The mean coef®cient of variation in GFR of each patient from day to day was 5%.
Kidney volume. Magnetic resonance (MR) imaging of the kidneys was performed on 14 subjects from each intervention group and on all of the controls at baseline and after the 6 months intervention. Subjects were examined on a 1.0 T MR imaging system (Siemens Impact, Erlangen, Germany). Axial T1 weighted (TRaTE 600a15) spin-echo images were obtained with a slice thickness of 5 mm. The images were transferred to a workstation where the renal parenchyma was outlined on all images by the same person. The area of the renal parenchyma on each slice was calculated automatically, and the sum of the areas of the slices of each kidney was multiplied by the slice thickness, to calculate the volume of the parenchyma of each kidney. In order to assess the reproducibility of the MR examination and the outlining of the renal parenchyma, one person was scanned 6 times, being repositioned between the scans (inter-examination variation). The volume of the parenchyma of both kidneys was calculated for each examination. Furthermore the renal parenchyma was outlined 6 times on the same examination and the volume was calculated for each outlining (intra-observer variation). Kidney volume was expressed as the total volume of both kidneys.
The intra-observer coef®cient of variation (CV) was 1.8%, while the inter-examination CV was 0.9%. Sources of error within each scan are patient motion and movement of the kidneys due to respiration. Under normal respiration the left and right kidney move up to 24 mm and 35 mm respectively. 9 Supposing that each subject breathes in the same way during the two examinations breathing should be a minor source of error since each subject is his or her own control. Ultrafast imaging techniques (echo planar sequences) performed during breathhold can eliminate respiration as a source of error but this technique was not available at the time of the examination. One source of interscan variation is that the subjects cannot be positioned in exactly the same way for both scans. This, however, seems to be a minor problem since the coef®cient of variation between scans in the reproducibility study was only 0.9%.
Speci®c glomerular ®ltration rate. Speci®c glomerular ®ltration rate was de®ned as GFRÂkidney volume 71 expressing renal function per unit renal tissue.
Body composition
Body composition was determined by a DXA scanning (Hologic 1000aW, Hologic, Inc., Waltham, MA, software version 5.61). Subjects wore only underwear and a cotton T-shirt during the scan. For quality control, spine phantoms were scanned daily, and for calibration, a body composition calibration phantom was scanned simultaneously at each examination.
Intra-abdominal adipose tissue (IAAT) was estimated from DXA scans and anthropometry by the equation given by Treuth et al: 10 IAAT cm 2 À208X2 4X62 sagittal diameterY cm 0X75 ageY y 1X73 waistY cm
0X78 trunk fatY %X
Total body water volume (TBW) was determined by an isotope dilution technique, using tritiated water with vacuum sublimation and scintillation counting. 11 Initially, blood was taken for background correction, then 3.7 MBq (100 mCi) tritiated water was injected intravenously. When equilibration was obtained 2 h later, a second blood sample was drawn. TBW was calculated as TBW (C 1 V 1 )aC 2 where C 1 V 1 is the amount of tracer given and C 2 is ®nal concentration of 12 The total precision of a TBW determination is AE 1.03 l. 13 
Laboratory analyses
Venous blood samples were drawn from an antecubital vein after an overnight fast. Plasma was separated from blood cells by 3000 g centrifugation for 10 min and aliquots were stored at 7 20 C prior to analysis. Urinary concentrations of creatinine, albumin and sodium were measured in 24 h urine collections at baseline and after 3 and 6 months. Urine collection was initiated in the morning after ®rst urination and terminated with the following day's ®rst morning specimen. After weighing and density assessment aliquots of the 24 h collections were stored at 7 18 C prior to further analysis. Completeness of the 24 h urine collection was determined by the PABA check method, 14 in which subjects were given one 80 mg tablet of paraaminobenzoic acid (PABA) with meals 3 times a day. Limits for exclusion because of incorrect urine collection were set at 80% and b 120% recovery of PABA. Serum urea were determined enzymatically with a Cobas Mira-Analyzer (Boehringer Mannheim Gmbh, Mannheim, Germany). Serum and urine creatinine was determined in a Cobas by an enzymatic colorimetric method using a Unimate 7 CREA test kit (Roche, Strasbourg, France). Urinary excretion of albumin was determined turbidimetrically with a Cobas Mira Plus (Roche Diagnostic Systems, Basel, Switzerland) using a DAKO microalbuminuria test kit (DAKO, Glostrup, Denmark). Urinary excretion of sodium was analyzed by a Corning 410C¯ame photometer (Corning Ltd., Essex, England).
Statistical analysis
Unless otherwise stated results are given as means AE s.e.m. One-way ANOVA (least squares means) or a t-test were used to analyse differences between groups with respect to 0 ± 6 months' changes in GFR, kidney volume, speci®c glomerular ®ltration rate, serumcreatinine, Se-carbamide, U-albumin and U-creatinine. Changes in renal variables were compared both as measured values and after adjustment for differences in body weight change in accordance with the procedure suggested by Ravussin et al. 15 A forward stepwise regression was made in the cross-sectional study (all subjects together) with renal variables as dependents and with the following independent variables: age, body weight (BW), body surface area (BSA), fat mass (FM), fat-free mass (FFM), IAAT, TBW, dietary protein intake and protein energy %. A forward stepwise regression was applied to the 0 ± 6 month changes in renal variables (intervention groups). Independent variables were changes in BW, BSA, FM, FFM, IAAT, TBW, dietary protein, energy intake, dietary protein energy% (E%), fat E% and carbohydrate E%. At baseline, dietary protein intake was calculated from 24 h urine collections. 16 Changes in dietary protein were calculated as the difference between dietary protein estimated from baseline 24 h urine collections 16 and the sixth month's mean E% as registered in the food supply system. A linear regression was conducted for GFR, kidney volume, speci®c glomerular ®ltration and serum creatinine, with FFM and BSA as independent variables. Group difference in correlations with FFM and BSA, respectively, was tested by a least squares means procedure applied to the residuals. Statistics Analysis Package, SAS # 6.10 (SAS Institute, Cary, NC, USA) and SigmaStat # 1.0 (Jandel Scienti®c GmbH, Erkrath, Germany) were used in the statistical analysis. The level of signi®cance was set at P`0.05.
Results
Cross-sectional study
At baseline, dietary protein intake and all renal variables were similar in the 3 groups except for GFR being slightly lower in the HP group than in the C group (group difference (95% con®dence interval, CI): 15.6 mlamin (5.0 ± 26.3), P`0.05) and U-creatinine being slightly different in the two intervention groups (group difference 2.2 mmolad (0.2 ± 4.2)) ( Table 2) . One subject from each of the intervention groups had microalbuminuria of 87 and 37 mgad respectively. Exclusion of these subjects in the analyses did not change the outcome and both subjects' urinary albumin excretion were reduced to less then 4 mgad after the dietary intervention.
Mean body surface areas in all 3 groups were above the standard 1.73 m 2 (1.98 m 2 (1.95 ± 2.02)). FFM and BSA were equally strong determinants of GFR, kidney volume and serum creatinine, since the residuals (numerical values), following linear regressions against the two independents, were not different (GFR: mean difference 0.384 mlamin (7 1.58 to 0.82), NS).
Dietary protein intake was found to be a determinant of only S-urea. Baseline mean arterial BP correlated only with urinary albumin excretion (r 0.27, P`0.05). The changes in GFR and kidney volume induced by changes in dietary protein content remained after adjustment for changes in weight loss.
Urinary sodium (U-Na) excretions were equal in the three groups at baseline: 185.4AE 15.6, 163.1AE 12.1 and 133.5AE 22.2 mmolad in the LP, HP and C group, respectively.
Intervention study
Two subjects dropped out of each intervention group due to change of address or non-compliance, and one subject was excluded from the control group due to Low vs high-protein diet: renal effects A Rosenvinge Skov et al elective surgery. A total of 60 subjects completed the trial (92%), 23 in each intervention group and 14 in the control group.
The subjects' adherence to the dietary compositions in the two intervention groups was high as assessed by the excretion of 24 h UN, the marker of protein intake. After 1 month of dietary intervention, 24 h urinary nitrogen excretion increased signi®cantly in the HP group and decreased signi®cantly in the LP group (group difference 6.8 g (5.0 ± 8.7 g), P`0.0001). This group difference remained throughout the trial. Dietary protein intake increased in the HP group from a baseline value of 91.4 gad (81.0 ± 101.82) to a 6 months intervention average of 107.8 gad (102.2 ± 112.1 gad) (P`0.05), while correspondingly a decrease from 91.1 gad (82.5 ± 99.7 gad) to 70.4 gad (64.8 ± 76.0 gad) (P`0.05) was observed in the LP group (group difference: P`0.0002). This corresponded to an average daily protein intake of 1.6 gakg in the HP group and 1.0 gakg in the LP group (group difference 0.6 gakg (0.5 ± 0.8), P`0.001). Dietary protein intake did not change in the C group during the intervention period.
Weight loss after 6 months' dietary intervention was 5.1 kg in the LP group and 8.9 kg in the HP group (difference 3.7 kg (1.3 ± 6.2), P`0.001) whereas the weight remained stable in the C group. Fat loss was 4.3 kg in the LP group and 7.6 kg in the HP group, respectively (difference 3.3 kg (1.1 ± 5.5 kg), P`0.0001), whereas no changes occurred in the control group. Loss of fat-free mass was 0.9 kg in the LP group and 1.3 kg in the HP group (NS).
GFR decreased by 7.1 mlamin in the LP group, whereas it increased by 5.2 mlamin in the HP group (difference 12.3 mlamin (5.0 ± 19.6), P`0.05). In the C group the change of 2.8 mlamin was not different from 0 ( 7 1.0 to 6.6).
GFR expressed conventionally as GFRamin per 1.73 m 2 decreased by 4 ml in the LP group and increased by 8.8 ml in the HP group (difference 12.8 mlamin (6.7 ± 18.9), P`0.05). In the C group the decrease was 4 mlamin (difference HP vs control: 12.8 (5.8 ± 19.8), P`0.01).
Kidney volume in the LP group was found to be reduced by 6.2 cm 3 while the volume increased in the HP group by 9.1 cm 3 (group difference 15.2 cm 3 (1.5 ± 28.9), P`0.05). Kidney volume declined in the C group by 4.9 cm 3 (from 376 cm 3 at baseline) differing from both intervention groups (P`0.05). After 6 months' intervention the correlation between kidney volume and dietary protein intake was stronger (r 0.6, P`0.005) than that at baseline.
At baseline, speci®c GFR (GFRavolume) was 0.30, 0.29 and 0.33 mlaminacm (NS) in the LP, HP and C groups, respectively, and did not change during the intervention period.
S-urea decreased in the LP group by 0.5 mmolal and increased in the HP group by 1.4 mmolal (difference: 2.0 mmolal (1.0 ± 2.9), P`0.05); the HP group being different from the decline of`0.1 mmolal in the control group (P`0.05). There was a trend towards a reduction of urinary excretion of albumin in all groups, with no statistically signi®cant differences within or between groups. Similarly, the different levels of dietary protein produced no differences in urinary albumin excretion (Table 2) . No group differences were found in the other renal variables following the intervention. Adjusting renal variables for differences in body weight change did not alter the protein effect on change of renal variables. The change in S-urea was negatively associated with change in dietary protein intake (r 7 0.31, P`0.05) and there was a similar trend in change in urinary albumin excretion (r 7 0.21, P 0.2). In a forward stepwise regression each renal variable could be predicted by one or two of the applied independent variables presented in Table 3 . Change in S-urea was only associated with change in dietary protein intake whereas none of the independent variables could predict urinary albumin excretion (Table 3) . None of the independent variables could contribute to the prediction of serum-creatinine or speci®c GFR. U- Table 3 Determinants of 0 ± 6 months' changes in renal variables as assessed by a forward stepwise regression applied to the intervention groups. Independent variables were changes in: body weight (BW) , body surface area (BSA), fat mass (FM), fat-free mass (FFM), intra-abdominal adipose tissue (IAAT), total body water (TBW), dietary protein, energy intake, dietary protein energy% (E%), fat E% and carbohydrate E% 
Changes in dietary protein were calculated as the difference between dietary protein estimated from baseline 24 h urine collections 31 and 6th months' mean E% as registered in the food supply system. { r 2 for the total model, P for each component.
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Na was increased by 37.2 mmolad, 17.0 mmolad and 32.0 mmolad in the HP, LP and C group, respectively (no difference between groups).
Discussion
This study demonstrates that GFR and kidney volume in healthy overweight and obese individuals are altered by low-fat diets differing in protein energy %, independent of changes in body size and composition. Cross-sectionally FFM was the major determinant of baseline values of both GFR, kidney volume and serum-creatinine, explaining 21%, 50% and 24% of the variance respectively. Consistent with this, studies in patients with impaired renal function have shown that FFM is superior to total body weight in predicting creatinine clearance. In our cross-sectional study body weight only contributed signi®cantly to the variation in speci®c GFR, explaining an additional 22% together with age. The variation between individuals in GFR has been attributed to differences in body weight and height, and the currently used standard body measure that takes both variables into account is body surface area. 17 The use of BSA to normalize for differences in body size and composition may give rise to some error, as we found that BSA explained 20 ± 50% less of the variation in GFR, speci®c GFR and kidney volume than did FFM or body weight. However, none of the correlations using FFM or body weight produced signi®cantly better results than those using BSA. Thus, a ®rm conclusion in this overweight population cannot be reached, because of the close covariation between these measures.
In the intervention study our data demonstrated that 6 months' high dietary protein intake induced a signi®cant increase in GFR, whereas the low protein diet caused a decrease in GFR corresponding to a difference of 12.3 mlamin or approximately 10%. Similar changes were found in kidney volume, which was signi®cantly reduced by the low-protein diet and increased by the high-protein diet. However, the speci®c GFR, which is an expression of the ®ltration rate per unit kidney volume, did not change during any of the treatments. This suggests that these changes are adaptations of the renal function to changes in protein load. The changes in renal function and size occurred simultaneously with marked weight losses induced by the low-fat diets, and a larger weight loss was produced by the HP than by the LP diet. The weight losses were due to reductions in the size of both FFM and fat mass, and based on the cross-sectional analysis these changes are thought to decrease both GFR and kidney volume. However, after adjustment of the changes in kidney function and size for weight changes, the effect of dietary protein remained.
Supporting the renal effects of dietary protein, we ®nd a strong positive correlation between dietary protein intake and kidney volume both before and after the intervention study. We therefore conclude that the renal effects produced by the differences in dietary protein content are independent of the associated changes in body size and composition. Our ®ndings are consistent with observations in vegetarians, whose GFR has been found to be signi®cantly lower than that of omnivores, and with a recent observational study showing a positive correlation between dietary protein intake and creatinine clearance in normal individuals with large variations in dietary protein intakes. 5 The present study was carried out in overweight and slightly obese subjects with BMI within 25 ± 34 kgam 2 , which may limit the extent to which the results can be generalized to individuals of all weight categories. However, according to the NHANES III survey conducted in 1988 ± 94 about 55% of all adult Americans had a BMI b 25 kgam 2 , 18 and the proportion of overweight individuals is increasing globally. Therefore, our results may apply to the majority of the adult population.
Protein-rich meals have been found to increase GFR acutely by 10 ± 50%
19 ± 21 as has intravenous infusion of amino acids. 22, 23 Renal effects of shortterm modulations (a few days to 3 weeks) of dietary protein intake have also been addressed. 4, 24 In a study from the mid 1950s, a 14 d high-protein diet was found to modestly increase GFR in healthy subjects, whereas a low-protein diet decreased GFR. 24 A recent review concludes that most subsequent studies have con®rmed this ®nding. 25 As far as we know, the present study is the ®rst to investigate renal effects of a high-protein vs a low-protein diet following a randomized controlled intervention with a duration of more than 4 weeks.
We measured renal variables only at the beginning and termination of the 6 month trial, and hence the time course of the effect in the interval in between is unknown. It is likely that a plateau was reached as an expression of a fully adapted state to the high level of protein intake. It has been proposed that renal changes in response to alterations in habitual dietary protein intake can occur within one month but this probably requires much longer. 25 In support of this contention, reduced levels of GFR have been found in vegetarians consuming signi®cantly less dietary protein than omnivores. 26 In a recent observational study involving subjects with different habitual protein intakes an exponential dose ± response relationship between dietary protein intake and GFR was suggested to reach a saturation level at a GFR of 181 mlamin, which was observed at a daily dietary protein intake of 125 g. 5 In most other studies, however, differences between variable levels of dietary protein intakes have been expressed as absolute amounts consumed daily per kg body weight. Low protein intake has consistently been de®ned as being below 0.6 g protein per kg body Low vs high-protein diet: renal effects A Rosenvinge Skov et al weight, 4, 27 whereas high-protein intake has been de®ned as being above 1 gakg body weight 19, 28 and up to 2 gakg body weight. 29 In our study we used the ad libitum dietary principle, and we hence focused on the proportion of dietary energy deriving from protein rather than the absolute intake as measured in grams per kg body weight. Expressed in absolute amounts a mean of no more than 0.6 g dietary protein per kg body weight differentiated the two intervention groups, yet an effect was still apparent.
The effect of high and low levels of dietary protein on albumin excretion is of particular interest, as restriction of dietary protein intake has been shown to diminish the progression of microalbuminuria in diabetics. 30, 31 Furthermore, the`Brenner' hypothesis proposes that increased levels of GFR induce hyper®ltration and subsequent detrimental glomerulosclerosis. 1 However, our data in healthy subjects cannot support this hypothesis, as we found no signi®cant changes in urinary albumin excretion between any groups. However, there was a non-signi®cant reduction in the HP group amounting to 5 mga24 h (P`0.4). Moreover, a signi®cantly lower rate of urinary albumin excretion has been observed in vegans consuming 0.95 g proteinakgad as compared to omnivores consuming 1.29 gakgad. 26 This lower rate did not correlate with GFR and was therefore not accounted for by differences in GFR. 26 A decreased prevalence of microalbuminuria at high relative intakes of protein has recently been observed in insulin-dependent diabetics. 32 In agreement with this, changes in urinary albumin excretions in the present study were found to be inversely correlated to changes in dietary protein intake.
The mechanisms whereby a high-protein diet increases GFR may be of structural, haemodynamic and hormonal nature. Anyhow, adaptive mechanisms are assumed to take place. This is supported by studies of the relationship between renal weight and protein intake in rats 33 and by protein malnutrition and small kidneys in children. 34 In conclusion, our study shows that cross-sectionally there is a strong association between FFM and renal function in healthy individuals. In this strictly controlled intervention study long-term changes in dietary protein content were seen to induce corresponding adaptive changes in kidney size and GFR. Normoalbuminuric levels were unaltered in all groups. We therefore conclude that a high dietary protein intake does not appear to have adverse effects on renal function in individuals without renal impairment.
